Genetic Technologies (GENE) Short Interest Ratio & Short Volume

Short interest is the volume of Genetic Technologies shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 25,500 shares of GENE short. Learn More on Genetic Technologies' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GENE shares currently have a short interest ratio of 1.0. Learn More on Genetic Technologies's short interest ratio.

Genetic Technologies saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 25,500 shares, an increase of 62.4% from the previous total of 15,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Genetic Technologies: BioCardia, Inc. (0.98%), Organovo Holdings, Inc. (4.09%), Coeptis Therapeutics Holdings, Inc. (0.57%), Creative Medical Technology Holdings, Inc. (1.55%), Titan Pharmaceuticals, Inc. (1.99%), Palisade Bio, Inc. (21.34%), Fresh Tracks Therapeutics, Inc. (0.17%), TRACON Pharmaceuticals, Inc. (7.29%), Senti Biosciences, Inc. (1.05%), TC Biopharm (Holdings) Plc (5.87%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling GENE is an investing strategy that aims to generate trading profit from Genetic Technologies as its price is falling. GENE shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Genetic Technologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GENE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GENE, twice per month. The most recent reporting period available is April, 30 2024.